Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-02 4:06 pm Purchase | 2023-05-25 | 13D | TSCAN THERAPEUTICS INC TCRX | Baker Bros. Advisors LP | 2,793,938 6.500% | 9,146 (+0.33%) | Filing History |
| 2023-05-24 5:11 pm Purchase | 2023-05-23 | 13D | ACADIA PHARMACEUTICALS INC ACAD | Baker Bros. Advisors LP | 43,227,599 26.500% | 920,810 (+2.18%) | Filing History |
| 2023-05-24 4:31 pm Purchase | 2023-05-18 | 13D | PRELUDE THERAPEUTICS INC PRLD | Baker Bros. Advisors LP | 10,219,080 19.500% | 92,663 (+0.92%) | Filing History |
| 2023-05-05 4:33 pm Sale | 2023-05-03 | 13D | BEONE MEDICINES LTD. AMERICAN ONC | Baker Bros. Advisors LP | 152,978,037 13.000% | -1,337,453 (-0.87%) | Filing History |
| 2023-05-05 4:24 pm Purchase | 2023-05-05 | 13D | BELLICUM PHARMACEUTICALS INC C BLCM | Baker Bros. Advisors LP | 2,197,919 19.990% | 1,948,795 (+782.26%) | Filing History |
| 2023-05-03 4:15 pm Sale | 2023-05-01 | 13D | SEAGEN INC SGEN | Baker Bros. Advisors LP | 45,074,469 24.000% | -2,159,182 (-4.57%) | Filing History |
| 2023-03-15 4:09 pm Purchase | 2023-03-13 | 13D | INCYTE CORPORATION INCY | Baker Bros. Advisors LP | 36,641,462 16.400% | 7,108 (+0.02%) | Filing History |
| 2023-03-13 4:30 pm Purchase | 2023-03-12 | 13D | SEATTLE GENETICS INC SGEN | Baker Bros. Advisors LP | 47,233,651 25.300% | 10,043 (+0.02%) | Filing History |
| 2023-03-10 4:55 pm Purchase | 2023-03-10 | 13D | TALIS BIOMEDICAL CORP COM TLIS | Baker Bros. Advisors LP | 2,505,086 66.200% | 4,750 (+0.19%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | AKERO THERAPEUTICS INC AKRO | Baker Bros. Advisors LP | 2,368,378 5.100% | 2,368,378 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | VERSARTIS INC ARAV | Baker Bros. Advisors LP | 4,586,404 7.500% | 3,160,094 (+221.56%) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | SURROZEN INC SRZN | Baker Bros. Advisors LP | 55,556 2.300% | -166,666 (-75.00%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | HOOKIPA PHARMA INC HOOK | Baker Bros. Advisors LP | 347,554 6.600% | 347,554 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | OPTHEA LTD SPONSORED ADR OPTEY | Baker Bros. Advisors LP | 31,627,844 6.800% | 5,200,323 (+19.68%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 180,913 9.990% | 180,913 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | 2SEVENTY BIO INC TSVT | Baker Bros. Advisors LP | 2,062,744 5.400% | 2,062,744 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | VERASTEM, INC. VSTM | Baker Bros. Advisors LP | 2,249,075 13.500% | 458,106 (+25.58%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | Baker Bros. Advisors LP | 19,184,794 9.950% | 720,050 (+3.90%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | ZYMEWORKS INC ZYME | Baker Bros. Advisors LP | 3,814,196 5.900% | 3,814,196 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | CERUS CORP CERS | Baker Bros. Advisors LP | 16,087,422 9.100% | 2,354,363 (+17.14%) | Filing History |